September 14th 2023
The federal agency says infants of a certain age should receive this monoclonal antibody to protect against the virus.
Can Immunomodulators Reduce Recovery Time in Patients Hospitalized With COVID-19 Pneumonia?
July 11th 2023Researchers investigated abatacept, cenicriviroc, and infliximab, but found that these medications did not significantly impact the time to recovery from COVID-19 pneumonia compared to placebo.
Read More
New Regulatory Filings Advance Moderna's mRNA-1345 RSV Vaccine
July 5th 2023Moderna's RSV vaccine (mRNA-1345) moves closer to regulatory approval with positive data and key submissions to the US FDA, European Medicines Agency, Switzerland's Swissmedic, and Australia's Therapeutic Goods Administration.
Read More
Unraveling the Connection: How Air Pollution Aggravates COVID-19 and Prolongs Hospital Stays
June 23rd 2023Even low levels of air pollution make COVID-19 worse, this study found. Air pollution exposure was associated with more severe disease, longer hospitalization periods, and an increased likelihood of intensive care admission.
Read More
CDC Advisory Panel Recommends RSV Vaccines for Older Adults
June 22nd 2023Older adults should receive the GSK or Pfizer RSV vaccine this fall, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted yesterday. The recommendation is expected to be finalized by CDC director Dr. Rochelle Walensky.
Read More
AI-Driven Advancements Pave the Way to Test for COVID-19 and Hepatitis at Home
May 18th 2023These new tests, conducted in a single tube within minutes, could enable at-home testing for various diseases. By incorporating CRISPR technology, the test achieves high reliability by distinguishing between false and true positives.
Read More
WHO Declares End of COVID-19 Global Health Emergency, Walensky to Step Down as CDC Director
May 5th 2023On the same day WHO Director-General Tedros Adhanom Ghebreyesus declared the end of the COVID-19 public health emergency, CDC Director Rochelle Walensky announced she will be stepping down at the end of June.
Read More
Contextualizing the First RSV Vaccine: How Past Failures Informed Current Successes
May 4th 2023RSV expert Steven Varga, PhD, describes the failed vaccine trials that paved the way for the world's first respiratory syncytial virus (RSV) vaccine, as well as the innovations still needed to protect vulnerable populations against RSV infection.
Read More